Decreased risk of underdosing with continuous infusion versus intermittent administration of cefotaxime in patients with sickle cell disease and acute chest syndrome
Article in PLOS ONE (April 2024)
The most recent citing publications are shown below. View all 134 publications that cite this research output on Dimensions.
Antimicrobial therapy in severe septic ICU major burn patients to combat bacterial resistance by pharmacokinetic-pharmacodymamics of vancomycin, meropenem, and piperacillin, cultures, and inflammatory biomarkers
Article in Pharmacy & Pharmacology International Journal (February 2024)
Chemical stability and physical compatibility of meropenem in admixtures for continuous and extended intravenous infusions
Article in Enfermedades Infecciosas y Microbiología Clínica (December 2023)